Abstract
Purpose
Despite the widespread use of multivitamin/mineral supplements, the effects of multivitamin/mineral on cardiovascular disease (CVD) remain inconclusive. We aimed to prospectively investigate how multivitamin/mineral use is associated with CVD.
Methods
This population-based cohort study included 465,278 men and women who participated in the UK Biobank and were free from CVD at baseline. Participants were enrolled between 2006 and 2010 and followed-up until the end of 2018. Data on supplement use including multivitamin/mineral were collected using self-reported questionnaires. Cox proportional hazards models were used to estimate the hazard ratios of CVD events in relation to multivitamin/mineral use.
Results
During the follow-up, we identified 25,772 cases of CVD events, 4754 cases of CVD mortality, 18,728 cases of coronary heart disease, 6726 cases of myocardial infarction, and 4561 cases of stroke. The multivariable-adjusted hazard ratios associated with multivitamin/mineral use were 0.96 (95% CI: 0.93, 0.99) for CVD events, 0.92 (0.86, 1.00) for CVD mortality, 0.96 (0.93, 0.99) for coronary heart disease, and 0.92 (0.86, 0.97) for myocardial infarction. Subgroup analysis suggested that multivitamin/mineral use was associated with a significantly lower risk of CVD events in participants aged < 60 years and in former and current smokers (P for interaction ≤ 0.01). Sensitivity analyses showed no substantial change in the results when we excluded participants who developed CVD events during the first 2 years of follow-up.
Conclusion
Multivitamin/mineral supplementation was associated with very modest reductions in CVD events. Age and smoking might modify these associations.
Similar content being viewed by others
References
Neuhouser ML (2003) Dietary supplement use by American women: challenges in assessing patterns of use, motives and costs. J Nutr 133(6):1992s–1996s. https://doi.org/10.1093/jn/133.6.1992S
Kim J, Choi J, Kwon SY, McEvoy JW, Blaha MJ, Blumenthal RS, Guallar E, Zhao D, Michos ED (2018) Association of multivitamin and mineral supplementation and risk of cardiovascular disease: a systematic review and meta-analysis. Circ Cardiovasc Qual Outcomes 11(7):e004224. https://doi.org/10.1161/circoutcomes.117.004224
Sesso HD, Christen WG, Bubes V, Smith JP, MacFadyen J, Schvartz M, Manson JE, Glynn RJ, Buring JE, Gaziano JM (2012) Multivitamins in the prevention of cardiovascular disease in men: the Physicians’ Health Study II randomized controlled trial. JAMA 308(17):1751–1760. https://doi.org/10.1001/jama.2012.14805
Hercberg S, Galan P, Preziosi P, Bertrais S, Mennen L, Malvy D, Roussel AM, Favier A, Briançon S (2004) The SUVIMAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. Arch Intern Med 164(21):2335–2342. https://doi.org/10.1001/archinte.164.21.2335
Sherman RE, Anderson SA, Dal Pan GJ, Gray GW, Gross T, Hunter NL, LaVange L, Marinac-Dabic D, Marks PW, Robb MA, Shuren J, Temple R, Woodcock J, Yue LQ, Califf RM (2016) Real-world evidence—what is it and what can it tell us? N Engl J Med 375(23):2293–2297. https://doi.org/10.1056/NEJMsb1609216
Rautiainen S, Akesson A, Levitan EB, Morgenstern R, Mittleman MA, Wolk A (2010) Multivitamin use and the risk of myocardial infarction: a population-based cohort of Swedish women. Am J Clin Nutr 92(5):1251–1256. https://doi.org/10.3945/ajcn.2010.29371
Dong JY, Iso H, Kitamura A, Tamakoshi A (2015) Multivitamin use and risk of stroke mortality: the Japan collaborative cohort study. Stroke 46(5):1167–1172. https://doi.org/10.1161/strokeaha.114.008270
Adebamowo SN, Feskanich D, Stampfer M, Rexrode K, Willett WC (2017) Multivitamin use and risk of stroke incidence and mortality amongst women. Eur J Neurol 24(10):1266–1273. https://doi.org/10.1111/ene.13358
Rautiainen S, Lee IM, Rist PM, Gaziano JM, Manson JE, Buring JE, Sesso HD (2015) Multivitamin use and cardiovascular disease in a prospective study of women. Am J Clin Nutr 101(1):144–152. https://doi.org/10.3945/ajcn.114.088310
Messerer M, Håkansson N, Wolk A, Akesson A (2008) Dietary supplement use and mortality in a cohort of Swedish men. Br J Nutr 99(3):626–631. https://doi.org/10.1017/s0007114507812049
Rautiainen S, Rist PM, Glynn RJ, Buring JE, Gaziano JM, Sesso HD (2016) Multivitamin use and the risk of cardiovascular disease in men. J Nutr 146(6):1235–1240. https://doi.org/10.3945/jn.115.227884
Li K, Kaaks R, Linseisen J, Rohrmann S (2012) Vitamin/mineral supplementation and cancer, cardiovascular, and all-cause mortality in a German prospective cohort (EPIC-Heidelberg). Eur J Nutr 51(4):407–413. https://doi.org/10.1007/s00394-011-0224-1
Sudlow C, Gallacher J, Allen N, Beral V, Burton P, Danesh J, Downey P, Elliott P, Green J, Landray M, Liu B, Matthews P, Ong G, Pell J, Silman A, Young A, Sprosen T, Peakman T, Collins R (2015) UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med 12(3):e1001779. https://doi.org/10.1371/journal.pmed.1001779
Ma H, Li X, Sun D, Zhou T, Ley SH, Gustat J, Heianza Y, Qi L (2019) Association of habitual glucosamine use with risk of cardiovascular disease: prospective study in UK Biobank. BMJ (Clin Res ed) 365:l1628. https://doi.org/10.1136/bmj.l1628
Tyrrell J, Jones SE, Beaumont R, Astley CM, Lovell R, Yaghootkar H, Tuke M, Ruth KS, Freathy RM, Hirschhorn JN, Wood AR, Murray A, Weedon MN, Frayling TM (2016) Height, body mass index, and socioeconomic status: mendelian randomisation study in UK Biobank. BMJ (Clin Res ed) 352:i582. https://doi.org/10.1136/bmj.i582
Li ZH, Zhong WF, Liu S, Kraus VB, Zhang YJ, Gao X, Lv YB, Shen D, Zhang XR, Zhang PD, Huang QM, Chen Q, Wu XB, Shi XM, Wang D, Mao C (2020) Associations of habitual fish oil supplementation with cardiovascular outcomes and all cause mortality: evidence from a large population based cohort study. BMJ (Clin Res ed) 368:m456. https://doi.org/10.1136/bmj.m456
Bull FC, Al-Ansari SS, Biddle S, Borodulin K, Buman MP, Cardon G, Carty C, Chaput JP, Chastin S, Chou R, Dempsey PC, DiPietro L, Ekelund U, Firth J, Friedenreich CM, Garcia L, Gichu M, Jago R, Katzmarzyk PT, Lambert E, Leitzmann M, Milton K, Ortega FB, Ranasinghe C, Stamatakis E, Tiedemann A, Troiano RP, van der Ploeg HP, Wari V, Willumsen JF (2020) World Health Organization 2020 guidelines on physical activity and sedentary behaviour. Br J Sports Med 54(24):1451–1462. https://doi.org/10.1136/bjsports-2020-102955
Holmquist C, Larsson S, Wolk A, de Faire U (2003) Multivitamin supplements are inversely associated with risk of myocardial infarction in men and women–Stockholm Heart Epidemiology Program (SHEEP). J Nutr 133(8):2650–2654. https://doi.org/10.1093/jn/133.8.2650
Bailey RL, Fakhouri TH, Park Y, Dwyer JT, Thomas PR, Gahche JJ, Miller PE, Dodd KW, Sempos CT, Murray DM (2015) Multivitamin-mineral use is associated with reduced risk of cardiovascular disease mortality among women in the United States. J Nutr 145(3):572–578. https://doi.org/10.3945/jn.114.204743
Watkins ML, Erickson JD, Thun MJ, Mulinare J, Heath CW Jr (2000) Multivitamin use and mortality in a large prospective study. Am J Epidemiol 152(2):149–162. https://doi.org/10.1093/aje/152.2.149
Jenkins DJA, Spence JD, Giovannucci EL, Kim YI, Josse RG, Vieth R, Sahye-Pudaruth S, Paquette M, Patel D, Blanco Mejia S, Viguiliouk E, Nishi SK, Kavanagh M, Tsirakis T, Kendall CWC, Pichika SC, Sievenpiper JL (2021) Supplemental vitamins and minerals for cardiovascular disease prevention and treatment: JACC focus seminar. J Am Coll Cardiol 77(4):423–436. https://doi.org/10.1016/j.jacc.2020.09.619
Salonen RM, Nyyssönen K, Kaikkonen J, Porkkala-Sarataho E, Voutilainen S, Rissanen TH, Tuomainen TP, Valkonen VP, Ristonmaa U, Lakka HM, Vanharanta M, Salonen JT, Poulsen HE (2003) Six-year effect of combined vitamin C and E supplementation on atherosclerotic progression: the Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) Study. Circulation 107(7):947–953. https://doi.org/10.1161/01.cir.0000050626.25057.51
Messner B, Bernhard D (2014) Smoking and cardiovascular disease: mechanisms of endothelial dysfunction and early atherogenesis. Arterioscler Thromb Vasc Biol 34(3):509–515. https://doi.org/10.1161/atvbaha.113.300156
Rautiainen S, Wang L, Lee IM, Manson JE, Gaziano JM, Buring JE, Sesso HD (2016) Multivitamin use and the risk of hypertension in a prospective cohort study of women. J Hypertens 34(8):1513–1519. https://doi.org/10.1097/hjh.0000000000000973
Steinberg D, Witztum JL (2002) Is the oxidative modification hypothesis relevant to human atherosclerosis? Do the antioxidant trials conducted to date refute the hypothesis? Circulation 105(17):2107–2111. https://doi.org/10.1161/01.cir.0000014762.06201.06
Hansson GK (2005) Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352(16):1685–1695. https://doi.org/10.1056/NEJMra043430
Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis (2002). JAMA 288(16):2015–2022. doi:https://doi.org/10.1001/jama.288.16.2015
McNulty H, Pentieva K, Hoey L, Ward M (2008) Homocysteine, B-vitamins and CVD. Proc Nutr Soc 67(2):232–237. https://doi.org/10.1017/s0029665108007076
McGreevy C, Williams D (2011) New insights about vitamin D and cardiovascular disease: a narrative review. Ann Intern Med 155(12):820–826. https://doi.org/10.7326/0003-4819-155-12-201112200-00004
Rose AH, Hoffmann PR (2015) Selenoproteins and cardiovascular stress. Thromb Haemost 113(3):494–504. https://doi.org/10.1160/th14-07-0603
Muñoz-Castañeda JR, Pendón-Ruiz de Mier MV, Rodríguez M, Rodríguez-Ortiz ME (2018) Magnesium replacement to protect cardiovascular and kidney damage? Lack of prospective clinical trials. Int J Mol Sci. https://doi.org/10.3390/ijms19030664
Acknowledgements
We thank UK Biobank participants. This research has been conducted using the UK Biobank Resource (application No 52632).
Funding
This study is supported by the National Natural Science Foundation of China (82173648), Innovative Talent Support Plan of the Medical and Health Technology Project in Zhejiang Province (2021422878), Internal Fund of Ningbo Institute of Life and Health Industry, University of Chinese Academy of Sciences (2020YJY0212), Ningbo Clinical Research Center for Digestive System Tumors (2019A21003), and Sanming Project of Medicine in Shenzhen (SZSM201803080).
Author information
Authors and Affiliations
Contributions
LH and YZ: conceptualized the manuscript; BC, CZ, and LH: contributed to the literature search and interpretation, the statistical analysis, the writing of the paper, and refining of figures and tables; RZ and MW: conducted the data collection; LH and YZ had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis; and all authors: reviewed and revised the manuscript, read and approved the final manuscript.
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical standards
This study was performed under generic ethical approval obtained by UK Biobank investigators from the National Health Service National Research Ethics Service (Ref: 11/NW/0.0382) and all participants provided written informed consent. The current analyses were carried out under application number 52632.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Che, B., Zhong, C., Zhang, R. et al. Multivitamin/mineral supplementation and the risk of cardiovascular disease: a large prospective study using UK Biobank data. Eur J Nutr 61, 2909–2917 (2022). https://doi.org/10.1007/s00394-022-02865-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00394-022-02865-4